CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOACaptura de pantalla 2022 09 14 a las 10.27.10    

Chromatin, cancer and the ubiquitin system

Research summary:

DNA replication is a central process in cell biology that mediates the copy of cellular DNA to ensure the faithful transmission of genetic information through cell division. Our group is interested in unraveling the mechanisms of control of DNA replication by the protein modifiers ubiquitin and SUMO. We have described that active replication forks present a SUMO rich environment that is maintained by the action of the deubiquitinase USP7 and is essential for DNA replication (Lecona et al., NSMB 2016). We have proposed that the group modification of the replication machinery plays a role during DNA replication (Lecona and Fernández Capetillo, Bioessays 2016) and the inhibition of USP7 leads to the disassembly of the replisome and a premature activation of the mitotic program that results in cell death (Galarreta et al., under revision). At the moment we are working to determine the functions of the group SUMOylation of the replisome and its interplay with the ubiquitination of replication factors.

One of the functions of SUMO and ubiquitin in chromatin is tagging proteins for their extraction by the AAA ATPase VCP through their recognition by specific partners. Our work has shown that VCP, in association with its adaptor FAF1, cooperates with the deubiquitinase USP7 to control the SUMO and ubiquitin equilibrium during DNA replication (Franz, Valledor et al, under revision). Following this work, we are now trying to understand how VCP affects the dynamics of the replication forks and to determine its targets in the replisome.

In addition, we are interested in the response to the challenges that hinder the advance of replication forks, known as replication stress. In the last years the replication stress response (RSR) has been put forward as a promising target in cancer. Initially the RSR constitutes a barrier for transformation but once cancer cells overcome this barrier their accelerated proliferation increases replication stress and makes them highly dependent on the RSR. We are analyzing the functions of the SUMO pathway and VCP in the RSR and its potential applications for cancer treatment. We are using breast cancer cell models with mutations in BRCA1, a central factor in homologous recombination, to explore the therapeutic potential of inhibitors of SUMOylation and VCP, since these tumors have been shown to be sensitive to the inhibition of the RSR.


Figure 1. Post-translational modification of proteins in chromatin is essential for the control of DNA replication. Ubiquitin and SUMO are emerging as key modulators of this process and may represent an interesting target for cancer treatment.


* For external calls please dial 34 91196 followed by the extension number
Last nameNameLaboratoryExt.*e-mailProfessional category
Churcher Scott Brian4094486sbchurcher(at)cbm.csic.esM3 Predoc.formación
Fuente GonzálezAna Deodora de la 4094486a.fuente(at)cbm.csic.esM3 66,66%
Gil PlazaAlba4094486alba.gil(at)cbm.csic.esM2 50%
Gómez MoyaAlicia4094486a.gomez.moya(at)cbm.csic.esM3 Predoc.formación
Lecona SagradoEmilio4094736elecona(at)cbm.csic.esE.Científicos Titulares de Organismos Públicos de Investigación
Martín RufoRodrigo4094486rmartin(at)cbm.csic.esM2 66,66%

Relevant publications:

  • Galarreta A, Valledor P, Ubieto-Capella P, Lafarga V, Zarzuela E, Muñoz J, Malumbres M, Lecona E*, Fernández-Capetillo O. “USP7 limits CDK1 activity throughout the cell cycle” EMBO J (2021) doi: 10.15252/embj.201899692, online ahead of print *Co-corresponding autor
  • El Motiam A, de la Cruz-Herrera CF, Vidal S, Seoane R, Baz-Martínez M, Bouzaher YH, Lecona E, Esteban M, Rodríguez MS, Vidal A, Collado M, Rivas C. “SUMOylation modulates the satbility and function of PI·K-p110b” Cell Mol Life Sci (2021) doi: 10.1007/s00018-021-03826-6, online ahead of print.
  • Lecona E, Fernández-Capetillo O. “Targeting ATR in Cancer” Nature Reviews Cancer (2018) 18: 586-595
  • Mayor-Ruiz C, Olbrich T, Drosten M, Lecona E, Vega-Sendino M, Ortega S, Dominguez O, Barbacid M, Ruiz S, Fernandez-Capetillo O. “ERF deletion rescues RAS deficiency in mouse embryonic stem cells” Genes & Development (2017) 32: 568-576
  • Lecona E, Fernández-Capetillo O. “An equilibrium of SUMO and Ubiquitin during DNA replication” Bioessays (2016) 38: 1209-17
  • Nieto-Soler M, Morgado-Palacin I, Lafarga V, Lecona E, Murga M, Callen E, Azorin J, Alonso J, López-Contreras AJ, Nussenzweig A, Fernandez-Capetillo O. “Efficacy of ATR inhibitors as single agents in Ewing Sarcoma” Oncotarget (2016) 13: 58759-67.
  • Murga M, Lecona E, Kamileri I, Lugli N, Sotiriou S, Días M, Antón ME, Méndez J, Halazonetis T, Fernández-Capetillo O. “POLD3 is haploinsufficient for DNA replication in mice” Molecular Cell (2016) 63: 877-83.
  • Lecona E, Rodríguez-Acebes S, Specks J, López-Contreras A, Ruppen I, Murga M, Muñoz J, Méndez J, Fernández-Capetillo O. “USP7 is a SUMO deubiquitinase essential for DNA replication” Nature Structural & Molecular Biology (2016) 23: 270-7 Co-corresponding author
  • Lecona E, Narendra V, Reinberg D. “USP7 cooperates with SCML2 to regulate the activity of PRC1” Molecular and Celullar Biology (2015) 35: 1157-68.
  • Lecona E, Fernández-Capetillo O. “Replication Stress and Cancer: It Takes Two to Tango” Experimental Cell Research (2014) 329: 26-34.
  • Bonasio R*, Lecona E*, Narendra V, Voigt P, Parisi F, Kruger Y, Reinberg D. “Interactions with RNA direct the Polycomb group protein SCML2 to chromatin where it represses target genes” *Equal contribution. eLife (2014) 3:
  • Lecona E, Rojas LA, Bonasio R, Johnston A, Fernández-Capetillo O, Reinberg D. “Polycomb protein SCML2 regulates the cell cycle by binding and modulating CDK/CYCLIN/p21 complexes” PLoS Biology (2013) 11: e1001737.
  • Bonasio, R., Lecona, E., Reinberg, D. “MBT domains in development and disease” Seminars in Cellular and Developmental Biology (2010) 21:221-230.

NOTE! This site uses cookies and similar technologies.

If you not change browser settings, you agree to it. Learn more

I understand


What are cookies?

A cookie is a file that is downloaded to your computer when you access certain web pages. Cookies allow a web page, among other things, to store and retrieve information about the browsing habits of a user or their equipment and, depending on the information they contain and the way they use their equipment, they can be used to recognize the user.

Types of cookies

Classification of cookies is made according to a series of categories. However, it is necessary to take into account that the same cookie can be included in more than one category.

  1. Cookies according to the entity that manages them

    Depending on the entity that manages the computer or domain from which the cookies are sent and treat the data obtained, we can distinguish:

    • Own cookies: those that are sent to the user's terminal equipment from a computer or domain managed by the editor itself and from which the service requested by the user is provided.
    • Third party cookies: those that are sent to the user's terminal equipment from a computer or domain that is not managed by the publisher, but by another entity that processes the data obtained through the cookies. When cookies are installed from a computer or domain managed by the publisher itself, but the information collected through them is managed by a third party, they cannot be considered as own cookies.

  2. Cookies according to the period of time they remain activated

    Depending on the length of time that they remain activated in the terminal equipment, we can distinguish:

    • Session cookies: type of cookies designed to collect and store data while the user accesses a web page. They are usually used to store information that only is kept to provide the service requested by the user on a single occasion (e.g. a list of products purchased).
    • Persistent cookies: type of cookies in which the data is still stored in the terminal and can be accessed and processed during a period defined by the person responsible for the cookie, which can range from a few minutes to several years.

  3. Cookies according to their purpose

    Depending on the purpose for which the data obtained through cookies are processed, we can distinguish between:

    • Technical cookies: those that allow the user to navigate through a web page, platform or application and the use of different options or services that exist in it, such as controlling traffic and data communication, identifying the session, access to restricted access parts, remember the elements that make up an order, perform the purchase process of an order, make a registration or participation in an event, use security elements during navigation, store content for the broadcast videos or sound or share content through social networks.
    • Personalization cookies: those that allow the user to access the service with some predefined general characteristics based on a series of criteria in the user's terminal, such as the language, the type of browser through which the user accesses the service, the regional configuration from where you access the service, etc.
    • Analytical cookies: those that allow the person responsible for them to monitor and analyse the behaviour of the users of the websites to which they are linked. The information collected through this type of cookies is used in the measurement of the activity of the websites, applications or platforms, and for the elaboration of navigation profiles of the users of said sites, applications and platforms, in order to introduce improvements in the analysis of the data of use made by the users of the service.

Cookies used on our website

The CBMSO website uses Google Analytics. Google Analytics is a simple and easy to use tool that helps website owners to measure how users interact with the content of the site. You can consult more information about the cookies used by Google Analitycs in this link.

Acceptance of the Cookies Policy

The CBMSO assumes that you accept the use of cookies if you continue browsing, considering that it is a conscious and positive action from which the user's consent is inferred. In this regard, you are previously informed that such behaviour will be interpreted that you accept the installation and use of cookies.

Knowing this information, it is possible to carry out the following actions:

  • Accept cookies: if the user presses the acceptance button, this warning will not be displayed again when accessing any page of the portal.
  • Review the cookies policy: the user can access to this page in which the use of cookies is detailed, as well as links to modify the browser settings.

How to modify the configuration of cookies

Using your browser you can restrict, block or delete cookies from any web page. In each browser the process is different, here we show you links on this particular of the most used browsers: